Skip to main content
Article thumbnail
Location of Repository

Malignant peritoneal mesothelioma. Is there a new treatment?

By Kakil Ibrahim Rasul and David J. Kerr

Abstract

The authors report a novel, alternative approach to treat malignant peritoneal mesothelioma (MPeM) targeting, vascular endothelial growth factor (VEGF) using anti-VEGF (bevacizumab) chemotherapy combination

Topics: Mesothelioma, Oncology, Rare Tumors, Medicine, R, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Publisher: PAGEPress Publications
Year: 2009
DOI identifier: 10.4081/rt.2009.e49
OAI identifier: oai:doaj.org/article:e8aeda695a954a83aefb790aac5da9e2
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/2036-3613 (external link)
  • https://doaj.org/toc/2036-3605 (external link)
  • http://www.pagepress.org/journ... (external link)
  • https://doaj.org/article/e8aed... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.